1996
DOI: 10.1007/978-3-642-61013-4_13
|View full text |Cite
|
Sign up to set email alerts
|

Pediatric Hepatic Drug Reactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2000
2000
2001
2001

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 176 publications
0
1
0
Order By: Relevance
“…A common histologic finding in the hepatotoxicity of valproic acid is microvesicular steatosis which is indicative of impairment of mitochondrial ß-oxidation (Fromenty & Pessayre 1997). Clinical and pathological features prove liver failure to be an idiosyncratic reaction, and therefore valproic acid was designated a contingent hepatotoxin (Roberts 1996;Zimmerman & Ishak 1996). The present study is based on the assumption that valproic acid could have an impact on hepatocellular defence mechanisms, so that the liver can no longer cope adequately with the challenge of endogenous or exogenous stress.…”
Section: Discussionmentioning
confidence: 99%
“…A common histologic finding in the hepatotoxicity of valproic acid is microvesicular steatosis which is indicative of impairment of mitochondrial ß-oxidation (Fromenty & Pessayre 1997). Clinical and pathological features prove liver failure to be an idiosyncratic reaction, and therefore valproic acid was designated a contingent hepatotoxin (Roberts 1996;Zimmerman & Ishak 1996). The present study is based on the assumption that valproic acid could have an impact on hepatocellular defence mechanisms, so that the liver can no longer cope adequately with the challenge of endogenous or exogenous stress.…”
Section: Discussionmentioning
confidence: 99%